{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:00:10Z","timestamp":1761541210865},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"DOI":"10.2146\/ajhp130711","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T17:57:21Z","timestamp":1416247041000},"page":"2045-2052","source":"Crossref","is-referenced-by-count":3,"title":["Interrater agreement for two systems used to determine the probability of heparin-induced thrombocytopenia"],"prefix":"10.1093","volume":"71","author":[{"given":"Maxime","family":"Dor\u00e9","sequence":"first","affiliation":[{"name":"Department of Pharmacy, H\u00f4pital du Sacr\u00e9-Coeur de Montr\u00e9al, Montr\u00e9al, Quebec, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Julie","family":"Frenette","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Research Center, H\u00f4pital du Sacr\u00e9-Coeur de Montr\u00e9al, and Faculty of Pharmacy, University of Montreal."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Chagnon","sequence":"additional","affiliation":[{"name":"Internal Medicine, Department of Medicine, H\u00f4pital du Sacr\u00e9-Coeur de Montr\u00e9al, and Clinical Professor of Medicine, Faculty of Medicine, University of Montreal."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Routhier","sequence":"additional","affiliation":[{"name":"Internal Medicine, Department of Medicine, H\u00f4pital du Sacr\u00e9-Coeur de Montr\u00e9al, and Clinical Professor of Medicine, Faculty of Medicine, University of Montreal."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Williamson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Research Center, H\u00f4pital du Sacr\u00e9-Coeur de Montr\u00e9al, and Associate Clinical Professor, Faculty of Pharmacy, University of Montreal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041605212792600_b1-0712045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2141.2003.04635.x","article-title":"Heparin-induced thrombocytopenia: pathogenesis and management","volume":"123","author":"Saad","year":"2003","journal-title":"Br J Haematol"},{"key":"2019041605212792600_b2-0712045","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ajh.21770","article-title":"Heparin-induced thrombocytopenia: current status and diagnostic challenges","volume":"85","author":"Otis","year":"2010","journal-title":"Am J Hematol"},{"key":"2019041605212792600_b3-0712045","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1160\/TH11-09-0677","article-title":"Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis","volume":"106","author":"Cuker","year":"2011","journal-title":"Thromb Haemost"},{"key":"2019041605212792600_b4-0712045","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1182\/blood-2011-11-376293","article-title":"How I treat heparin-induced thrombocytopenia","volume":"119","author":"Cuker","year":"2012","journal-title":"Blood"},{"key":"2019041605212792600_b5-0712045","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1538-7836.2008.03025.x","article-title":"Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays","volume":"6","author":"Warkentin","year":"2008","journal-title":"J Thromb Haemost"},{"key":"2019041605212792600_b6-0712045","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.lab.2005.08.003","article-title":"Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?","volume":"146","author":"Warkentin","year":"2005","journal-title":"J Lab Clin Med"},{"key":"2019041605212792600_b7-0712045","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2165\/00019053-200725110-00005","article-title":"Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis","volume":"25","author":"Patrick","year":"2007","journal-title":"Pharmacoeconomics"},{"key":"2019041605212792600_b8-0712045","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0002-9343(99)00124-2","article-title":"Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia","volume":"106","author":"Wallis","year":"1999","journal-title":"Am J Med"},{"key":"2019041605212792600_b9-0712045","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1161\/CIRCULATIONAHA.104.518563","article-title":"When heparins promote thrombosis: review of heparin-induced thrombocytopenia","volume":"111","author":"Jang","year":"2005","journal-title":"Circulation"},{"key":"2019041605212792600_b10-0712045","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pre-test clinical score (4 T\u2019s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2019041605212792600_b11-0712045","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1111\/j.1538-7836.2010.04059.x","article-title":"The HIT Expert Probability (HEP) score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion","volume":"8","author":"Cuker","year":"2010","journal-title":"J Thromb Haemost"},{"key":"2019041605212792600_b12-0712045","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2141.2003.04334.x","article-title":"Heparin-induced thrombocytopenia: pathogenesis and management","volume":"121","author":"Warkentin","year":"2003","journal-title":"Br J Haematol"},{"key":"2019041605212792600_b13-0712045","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1538-7836.2004.00949.x","article-title":"Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass","volume":"2","author":"Lillo-Le Louet","year":"2004","journal-title":"J Thromb Haemost"},{"key":"2019041605212792600_b14-0712045","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1538-7836.2009.03465.x","article-title":"Prospective evaluation of PF4\/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia","volume":"7","author":"Bakchoul","year":"2009","journal-title":"J Thromb Haemost"},{"key":"2019041605212792600_b15-0712045","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1592\/phco.31.2.138","article-title":"Assessment of the 4Ts pre-test clinical scoring system as a predictor of heparin-induced thrombocytopenia","volume":"31","author":"Strutt","year":"2011","journal-title":"Pharmaco-therapy"},{"key":"2019041605212792600_b16-0712045","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MBC.0b013e32835baccb","article-title":"Comparison of diagnostic performance of the heparin-induced thrombocytopenia expert probability and the 4Ts score in screening for heparin-induced thrombocytopenia","volume":"24","author":"Uaprasert","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2019041605212792600_b17-0712045","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1538-7836.2007.02617.x","article-title":"Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4\/heparin antibodies of the IgG, IgM, and IgA classes","volume":"5","author":"Greinacher","year":"2007","journal-title":"J Thromb Haemost"},{"key":"2019041605212792600_b18-0712045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1538-7836.2011.04552.x","article-title":"Prospective evaluation of the interobserver reliability of the 4Ts score in patients with suspected heparin-induced thrombocytopenia","volume":"10","author":"Nagler","year":"2012","journal-title":"J Thromb Haemost"},{"key":"2019041605212792600_b19-0712045","doi-asserted-by":"crossref","first-page":"470.e7","DOI":"10.1016\/j.jcrc.2014.02.004","article-title":"Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial","volume":"29","author":"Crowther","year":"2014","journal-title":"J Crit Care"},{"key":"2019041605212792600_b20-0712045","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12630-013-9933-7","article-title":"Thrombocytopenia in the critically ill: prevalence, incidence, risk factors, and clinical outcomes","volume":"60","author":"Williamson","year":"2013","journal-title":"Can J Anaesth"},{"key":"2019041605212792600_b21-0712045","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1378\/chest.13-0121","article-title":"Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes","volume":"144","author":"Williamson","year":"2013","journal-title":"Chest"},{"key":"2019041605212792600_b22-0712045","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1055\/s-0031-1291375","article-title":"Heparin-induced thrombocytopenia: real-world issues","volume":"37","author":"Linkins","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"2019041605212792600_b23-0712045","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/j.thromres.2009.10.021","article-title":"Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia","volume":"125","author":"Prechel","year":"2010","journal-title":"Thromb Res"},{"key":"2019041605212792600_b24-0712045","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/jth.12208","article-title":"Fc-gammaRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia","volume":"11","author":"Nazi","year":"2013","journal-title":"J Thromb Haemost"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/71\/23\/2045\/28451069\/ajhp2045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T05:21:34Z","timestamp":1555392094000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/71\/23\/2045\/5111106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":24,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp130711","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,12,1]]},"published":{"date-parts":[[2014,12,1]]}}}